Academic Journal
Q1Research and Practice in Thrombosis and Haemostasis
About Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis is a scholarly journal published by Elsevier B.V.. SCImago 2025 lists it in Q1, with an SJR of 1.066 and H-index of 49.
Coverage: 2017-2026. Research categories: Hematology (Q1).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Venous Thromboembolism Diagnosis and Management; Hemophilia Treatment and Research; Platelet Disorders and Treatments; Blood Coagulation and Thrombosis Mechanisms; Heparin-Induced Thrombocytopenia and Thrombosis; Blood properties and coagulation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
AngioJet Rheolytic Thrombectomy Under Superior Vena Cava Filter Protection for Acute Upper Extremity Deep Vein Thrombosis in Patients with Cancer: A Single-Center Retrospective Analysis
Shaobo Zhai, Jia Yu, Jifeng Sun, Yangyang Yu et al.
2026-10 · DOI: 10.1016/j.rpth.2026.107002Assay or Astray? Discrepancies in Efanesoctocog alfa Monitoring
Agathe HERB, Jordan WIMMER, Sarra DERBAL, Manon DOLT et al.
2026-10 · DOI: 10.1016/j.rpth.2026.106994Rapid Measurement of Direct Oral Anticoagulants for Clinical Decision-Making
Elizabeth Ronchetto, Jean Connors, Gabriel V. Fontaine, Kamran Hajiyev et al.
2026-10 · DOI: 10.1016/j.rpth.2026.106997Management of bleeding and non-elective invasive procedures in patients receiving direct oral anticoagulants (DOAC): a five-year single center observational study
Adeline PONTIS, Alexandre MANSOUR, Axelle MAURICE, Chloé ROUSSEAU et al.
2026-10 · DOI: 10.1016/j.rpth.2026.107003Targeted long-read sequencing identifies a novel 1.3 kb FGG deletion associated with variable bleeding and thrombotic phenotypes in hypofibrinogenemia.
Alexander Couzens, Frédéric Masclaux, Baptiste Micheli, Michel Guipponi et al.
2026-10 · DOI: 10.1016/j.rpth.2026.107001Multiplex complement profiling uncovers complement activation signatures in microvascular manifestations of antiphospholipid syndrome
Bin Cai, Can Huang, Yulan Chen, Yangzhong Zhou et al.
2026-10 · DOI: 10.1016/j.rpth.2026.106996Rapid Plasma-Based Screening of Fibrinolytic Activation in Trauma: A Single Center Observational Cohort Study
Anton Ilich, Izabela Pawlinski, Matthew J. Eckert, Linda E. Sousse et al.
2026-10 · DOI: 10.1016/j.rpth.2026.106999Hetrombopag in promoting platelet engraftment after hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 study
Jian Xiao, Jie Ji, Hai Yi, Lei Ma et al.
2026-10 · DOI: 10.1016/j.rpth.2026.106967Association between coffee consumption and risk of recurrent venous thromboembolism – Results from the Trøndelag Health Study and Tromsø Study
Melliane M. Olsen, Sigrid K. Brækkan, Kristian Hveem, Kjersti Grønning et al.
2026-10 · DOI: 10.1016/j.rpth.2026.106966Cryptogenic Stroke Associated with Low ADAMTS13 Activity without Microangiopathic Hemolytic Anemia: A Comparative Study of Clinical Features and Outcomes
Zhengrui Xiao, Yu-Chiang Chang, Johanna Seiden, Roha Saeed Memon et al.
2026-10 · DOI: 10.1016/j.rpth.2026.106998Biomechanical viscoelastic properties in Leg Muscles of People with Haemophilia: A Case Control Study
Marius Brühl, Fabian Tomschi, Andreas Christian Strauss, Joschua Wiese et al.
2026-10 · DOI: 10.1016/j.rpth.2026.107000A crowded podium in hemophilia A: when a low annualized bleeding rate is no longer enough to tell the contenders apart
Laurent Frenzel
2026-10 · DOI: 10.1016/j.rpth.2026.106942Early Outcomes After Venous Thromboembolism in Hispanic and Non-Hispanic Patients: Insights from the RIETE Registry
Lizbeth Cabrera, Alfonso Tafur, Leticia Guirado-Torrecillas, Jose Maria Pedrajas et al.
2026-09 · DOI: 10.1016/j.rpth.2026.106969Evolutionary constraint and population variation across coagulation genes
Omid Seidizadeh, Himani Chand, Andrea Cairo, Flora Peyvandi et al.
2026-09 · DOI: 10.1016/j.rpth.2026.106980Heavy Menstrual Bleeding in Women with a Bleeding Disorder of Unknown Cause: A common symptom impacting daily life functioning
Caroline M.A. Mussert, Floor Derikx, Amaury L.L. Monard, Bram Brandt et al.
2026-09 · DOI: 10.1016/j.rpth.2026.106950Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study
Hyung-Jun Lim, Kunye Kwak, Changgon Kim, Yoon Seok Choi et al.
2026-09 · DOI: 10.1016/j.rpth.2026.106992Association of the sarcopenia index based on the serum creatinine to cystatin C ratio and genetic risk with venous thromboembolism: A population-based cohort study
Yuyang Sun, Tingting Liu, Jun Deng, Xi Cao et al.
2026-09 · DOI: 10.1016/j.rpth.2026.106973Hemostatic function remains unaltered following therapeutic factor XIIa inhibition with garadacimab
Danny M. Cohn, Henriette Farkas, Marc A. Riedl, Harsha Shetty et al.
2026-09 · DOI: 10.1016/j.rpth.2026.106993Unexplained recurrent diffuse bleeding diathesis as a manifestation of non-aneurysmal intimomedial mucoid degeneration
Cynthia Frima, Jan Jaap Spijkstra, Bernadette Schurink, Adriaan G. Holleboom et al.
2026-09 · DOI: 10.1016/j.rpth.2026.106978Concizumab for the Management of Heavy Menstrual Bleeding in a Woman with Mild Hemophilia A
Yoko Mizoguchi, Maiko Shimomura, Yuko Teraoka, Teruhisa Fujii et al.
2026-09 · DOI: 10.1016/j.rpth.2026.106979Reviews
Community Reviews
Version History
September 25, 2026 at 7:56 am
September 25, 2026